2017Unpublished venueRequires access

Gestational Trophoblastic Disease

John R. Lurain, Michael J. Seckl, Julian C. Schink

Open publisher page 44 citations

Abstract

Gestational trophoblastic disease is a spectrum of interrelated abnormal proliferations of the placental trophoblast, encompassing benign hydatidiform moles (complete and partial) as well as gestational trophoblastic neoplasia, which includes invasive mole, choriocarcinoma, placental site trophoblastic tumor, and its related epithelioid trophoblastic tumor. Early detection of hydatidiform moles with ultrasonography and advances in uterine evacuation techniques have decreased serious bleeding and medical complications of molar pregnancy. The availability of accurate tests for measuring human chorionic gonadotropin as a disease-specific tumor marker and the introduction of chemotherapy into the management of gestational trophoblastic neoplasia have significantly reduced deaths so that the overall cure rate in treating these tumors is greater than 90% even in the presence of widely metastatic disease.

About this research paper

What this paper is about

Gestational trophoblastic disease is a spectrum of interrelated abnormal proliferations of the placental trophoblast, encompassing benign hydatidiform moles (complete and partial) as well as gestational trophoblastic neoplasia, which includes invasive mole, choriocarcinoma, placental site trophoblastic tumor, and its related epithelioid trophoblastic tumor. Early detection of hydatidiform moles with ultrasonography and advances in uterine evacuation techniques have decreased serious bleeding and medical complications of molar pregnancy. The availability of accurate tests for measuring human chorionic gonadotropin as a disease-specific tumor marker and the introduction of chemotherapy into the management of gestational trophoblastic neoplasia have significantly reduced deaths so that the overall cure rate in treating these tumors is greater than 90% even in the presence of widely metastatic disease.

Why it matters

OpenAlex reports 44 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Gestational trophoblastic disease is a spectrum of interrelated abnormal proliferations of the placental trophoblast, encompassing benign hydatidiform moles (complete and partial) as well as gestational trophoblastic neoplasia, which includes invasive mole, choriocarcinoma, placental site trophoblastic tumor, and its related epithelioid trophoblastic tumor. Early detection of hydatidiform moles with ultrasonography and advances in uterine evacuation techniques have decreased serious bleeding and medical complications of molar pregnancy. The availability of accurate tests for measuring human chorionic gonadotropin as a disease-specific tumor marker and the introduction of chemotherapy into the management of gestational trophoblastic neoplasia have significantly reduced deaths so that the overall cure rate in treating these tumors is greater than 90% even in the presence of widely metastatic disease.

Key concepts: Placental site trophoblastic tumor, Partial Hydatidiform Mole, Choriocarcinoma, Gestational trophoblastic disease, Trophoblastic Tumor, Molar pregnancy, Gestational trophoblastic neoplasia, Human chorionic gonadotropin

Related papers

Back to paper searchBrowse research topicsOriginal source
Gestational Trophoblastic Disease — Research Paper | ScholarLens